Clinical Trial Update: Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating inhaled sodium pyruvate for cystic fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled Sodium Pyruvate (sodium pyruvate inhalation)

Snippet

Sponsor: Emphycorp | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED